29 research outputs found
Changeable Manufacturing on the Network Level
AbstractAgility in the sense of changeability on the manufacturing network level, and here especially the business perspective, has received less attention than the other dimensions of changeability on the lower production levels, as well as in relation to the technological perspective. The present paper aims to enrich the concept of agility in the aforementioned sense, taking strategic management concepts into account that have so far received less attention in relation to changeability. Namely, we consider the concepts of lead factory, capacity pooling and allying, operational flexibility, and the concept of combining products, services and software as fruitful enrichments of the umbrella concept changeability. In so doing, we highlight interdependencies between agility and the analyzed concepts as well as the other changeability dimensions on the lower production level of factories or sites. On this basis, we formulate six hypotheses in consideration of the presented theoretical derivations. Hence, the methodological approach of our research is conceptual and hypothesis generating. Our work is supposed to build the basis for continuative conceptual and empirical research on agility
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
Background: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage 653 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage 653 CKD in a large cohort of patients affected by T1DM. Methods: A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici Diabetologi, AMD) initiative constitutes the study population. Urinary albumin excretion (ACR) and estimated GFR (eGFR) were retrieved and analyzed. The incidence of stage 653 CKD (eGFR < 60 mL/min/1.73 m2) or eGFR reduction > 30% from baseline was evaluated. Results: The mean estimated GFR was 98 \ub1 17 mL/min/1.73m2 and the proportion of patients with albuminuria was 15.3% (n = 654) at baseline. About 8% (n = 337) of patients developed one of the two renal endpoints during the 4-year follow-up period. Age, albuminuria (micro or macro) and baseline eGFR < 90 ml/min/m2 were independent risk factors for stage 653 CKD and renal function worsening. When compared to patients with eGFR > 90 ml/min/1.73m2 and normoalbuminuria, those with albuminuria at baseline had a 1.69 greater risk of reaching stage 3 CKD, while patients with mild eGFR reduction (i.e. eGFR between 90 and 60 mL/min/1.73 m2) show a 3.81 greater risk that rose to 8.24 for those patients with albuminuria and mild eGFR reduction at baseline. Conclusions: Albuminuria and eGFR reduction represent independent risk factors for incident stage 653 CKD in T1DM patients. The simultaneous occurrence of reduced eGFR and albuminuria have a synergistic effect on renal function worsening
Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
Several take issue with commentary on racial diversity . . . . High-dose glucosamine associated with polyuria and polydipsia in a dog . . . . Observations on perceived shortage of food animal veterinarians
Homeostasis Model Assessment (HOMA) closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria
Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria
Homeostasis Model Assessment (HOMA) closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
ACE genotype and endothelium-dependent vasodilation of conduit arteries and forearm microcirculation in humans
The ACE gene is a candidate gene for cardiovascular disease. Endothelial dysfunction is considered an intermediate phenotype in the pathogenesis of hypertension and atherosclerosis. We evaluated the role of ACE gene polymorphism in endothelial function of young healthy humans. We assessed ACE genotype (deletion [D]/insertion [I] polymorphism) in 92 young healthy individuals. In 88 of them, endothelium-dependent (flow-mediated) vasodilation and endothelium-independent (nitroglycerin-induced) vasodilation were measured in the common femoral artery and in the brachial (n=84) artery by echo Doppler technique. In 35 subjects, we also applied the forearm perfusion technique to quantify the responses of the forearm vascular bed to 3 increasing doses of 2 endothelium-dependent vasodilators (acetylcholine and bradykinin) and 1 endothelium-independent vasodilator (sodium nitroprusside). The D allele of the ACE gene was associated with a significant blunting (Delta approximately 26%) of endothelium-dependent vasodilation in the femoral artery (P=0.02) but not in the brachial artery (P=0.55) or in the forearm microcirculation (P=0.70 to 0.80). Endothelium-independent vasodilation was unaffected by the ACE genotype. In young healthy humans, the D allele of the ACE gene is associated with selective endothelial dysfunction of the femoral artery. It remains to be determined whether this association discloses a causal role in vascular, particularly peripheral artery, disease